Elaine Ullian - Vertex Pharmaceuticals Co-Lead Independent Director

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 35px;;'>VRT</div>
VRTX -- USA Stock  

 Earnings Call  This Week

Ms. Elaine S. Ullian is CoLead Independent Director of Vertex Pharmaceuticals Incorporated. Ms. Ullian was a member of our Board of Directors since 1997. Ms. Ullian served as President and Chief Executive Officer of Boston Medical Center, a private, notforprofit, 626bed, academic medical center with a communitybased focus, from 1996 through January 2010. From 1994 to 1996, she served as President and Chief Executive Officer of Boston University Medical Center Hospital. From 1987 to 1994, Ms. Ullian served as President and Chief Executive Officer of Faulkner Hospital. She also serves as a director of Thermo Fisher Scientific Inc. and Hologic, Inc
Age: 69  Director Since 2011      
617 341-6100  www.vrtx.com
Ullian holds a B.A. in political science from Tufts University and an M.P.H. from the University of Michigan.

Elaine Ullian Latest Insider Activity

Management Efficiency

The company currently holds 649.8 M in liabilities with Debt to Equity (D/E) ratio of 12.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals has Current Ratio of 3.37 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


Larry CordellOrigin Agritech Limited
Jeffrey KindlerPerrigo Company Plc
Joseph GoldsteinRegeneron Pharmaceuticals
Willie ReedZoetis
Geoffery MerszeiOrigin Agritech Limited
Sridar IyengarDr Reddys Laboratories Ltd
Geoffrey ParkerPerrigo Company Plc
Omkar GoswamiDr Reddys Laboratories Ltd
Hans HaslerDr Reddys Laboratories Ltd
William SteereZoetis
Rolf ClassonPerrigo Company Plc
George SingRegeneron Pharmaceuticals
William DoyleZoetis
Theodore SamuelstoPerrigo Company Plc
J MoreauDr Reddys Laboratories Ltd
Huda ZoghbiRegeneron Pharmaceuticals
Herman MorrisPerrigo Company Plc
Ashok GangulyDr Reddys Laboratories Ltd
Frank DAmelioZoetis
Michael TrimbleOrigin Agritech Limited
Robert ScullyZoetis

Entity Summary

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 2500 people.Vertex Pharmaceuticals Incorpor (VRTX) is traded on BATS Exchange in USA and employs 2,500 people.

Vertex Pharmaceuticals Leadership Team

William Young, Independent Director
Reshma Kewalramani, Executive Vice President - Global Medicines Development and Medical Affairs and Chief Medical Officer
Michael Parini, Executive Vice President and Chief Legal Officer
Alan Garber, Independent Director
Joshua Boger, Executive Director and Chairman of Science and Technology Committee
John Gray, Senior Vice President Genetic Therapies
Margaret McGlynn, Independent Director
Sangeeta Bhatia, Director
Terrence Kearney, Independent Director
Ian Smith, CFO, Executive Vice President
Paul Silva, Senior Vice President Corporate Controller
David Altshuler, Independent Director
Jeffrey Chodakewitz, Chief Medical Officer and Senior Vice President - Global Medicines Development
Elaine Ullian, Co-Lead Independent Director
Amit Sachdev, Senior Vice President - Global Government Strategy, Market Access and Value
David Greenway, Director
Charles Wagner, CFO, Executive Vice President
Bruce Sachs, Co-Lead Independent Director
Lloyd Carney, Independent Director
Michael Partridge, Vice President - Investor Relations
Yuchun Lee, Independent Director
Kimberly White, Senior Vice President and Chief Communications Officer
Stuart Arbuckle, Chief Commercial Officer and Executive VP
Thomas Graney, CFO, Senior Vice President
Charles Milstein, Executive Vice President Chief Legal and Administrative Officer
Jeffrey Leiden, Chairman of the Board and Presidentident, CEO

Stock Performance Indicators

Did you try this?

Run Aroon Oscillator Now


Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
All  Next Launch Module

Also Currentnly Active

Purchased less than 1 share of
a day ago
Traded for 229.54
Purchased over 90 shares of
a day ago
Traded for 4.36
Purchased over 200 shares of
a day ago
Traded for 114.47
Also please take a look at World Market Map. Please also try World Markets Correlation module to find global opportunities by holding instruments from different markets.